ImmuneBridge is building a world where high quality cell therapies can be rapidly designed and easily manufactured at commercial scale and ultralow cost.
| Website | http://www.immunebridge.com |
| Employees | 17 (7 on RocketReach) |
| Address | 2122 Bryant St, San Francisco, California 94110, US |
| Phone | +1 415-624-6411 |
| Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
| Keywords | Cancer Treatment, Cancer Immunotherapy, Cellular Immunotherapy, Immunotherapy Research, Stem Cell Therapy, Cancer Research, Oncology Therapeutics, Immunotherapeutic Agents, Hematologic Malignancies, Biopharmaceutical Development, Regenerative Medicine |
| Competitors | Moderna Therapeutics, Pfizer, AstraZeneca, Novavax, GSK, Sanofi, Merck & Co., Inc., Johnson & Johnson, Roche, AbbVie +45 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular ImmuneBridge employee's phone or email?
Nina Horowitz is the CEO of ImmuneBridge.
7 people are employed at ImmuneBridge.
ImmuneBridge is based in San Francisco, California.
The NAICS codes for ImmuneBridge are [541, 3254, 54, 325, 32].
The SIC codes for ImmuneBridge are [873, 87, 28, 283, 80].